Table 1.
Organism/distribution | Growth positive, n (%) | Gram positive, n (%) | S. aureus, n (%) | MRSA, n (%) | VRSA, n (%) |
---|---|---|---|---|---|
Sex | |||||
Male (n = 409) | 215 (52.6) | 93 (43.2) | 42 (19.5) | 29 (69.0) | 3 (10.3) |
Female (n = 386) | 149 (38.6) | 61 (40.9) | 32 (21.5) | 16 (50.0) | 2 (12.5) |
Clinical samples | |||||
Urine (n = 279) | 135 (48.3) | 32 (23.7) | 10 (7.4) | 3 (50.0) | 0 |
Sputum (n = 126) | 61 (48.4) | 29 (47.5) | 13 (21.3) | 5 (38.5) | 0 |
Blood (n = 118) | 20 (16.9) | 7 (35.0) | 6 (30.0) | 2 (33.3) | 0 |
Pus (n = 109) | 54 (49.5) | 34 (62.9) | 16 (29.6) | 14 (87.5) | 3 (21.4) |
Wound swab (n = 92) | 57 (61.9) | 42 (73.7) | 27 (47.4) | 21 (77.8) | 2 (9.5) |
∗Others (n = 71) | 17 (23.9) | 10 (58.8) | 2 (11.8) | 0 | 0 |
Hospital units | |||||
General ward (n = 370) | 160 (43.2) | 66 (41.3) | 32 (20.0) | 20 (62.5) | 2 (10.0) |
OPD (n = 171) | 91 (53.2) | 35 (38.5) | 15 (16.5) | 9 (60.0) | 1 (11.1) |
ICU (n = 125) | 65 (52.0) | 31 (47.6) | 17 (26.2) | 12 (70.5) | 2 (16.7) |
Gynae (n = 129) | 48 (37.2) | 22 (45.8) | 10 (20.8) | 4 (40.0) | 0 |
Total (n = 795) | 364 (45.8) | 154 (42.3) | 74 (20.3) | 45 (60.8) | 5 (11.1) |
Abbreviations: MRSA = methicillin-resistant Staphylococcus aureus; VRSA = vancomycin-resistant Staphylococcus aureus; ∗others = throat swab, vaginal swab, synovial fluid, and pleural fluid; percentage calculated on respective row total.